The dispute over the Medicare drug price negotiation program has moved from a war of words into the courtroom.

The U.S. Chamber of Commerce and the federal government on Friday presented oral arguments before U.S. District Judge Michael Newman in Dayton, Ohio. The program, which was established by the Inflation Reduction Act, aims to save $25 billion annually by 2031 through price negotiations for the drugs that are most costly to Medicare.

Attorney Jeffrey Bucholtz, representing the chamber, argued that the program violates drugmakers’ due process rights by giving the government power to effectively dictate prices for their products. “There is a very, very high risk, maybe a guarantee, but certainly a very, very high risk, that this regime will result in prices that are unfair,” he said.


NOT FOR REPRINT

© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

 

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.